Vycor Medical (VYCO) Gains from Investment Securities (2017 - 2019)
Vycor Medical (VYCO) posted quarterly Gains from Investment Securities of $749.0 for Q2 2019, up 723.08% year-over-year from $91.0 in Q2 2018, and up 723.08% quarter-over-quarter from $91.0 in Q2 2018.
Vycor Medical (VYCO) Gains from Investment Securities (2017 - 2019) Analysis & Trends
Vycor Medical (VYCO) has reported Gains from Investment Securities for 3 consecutive years, with $749.0 the latest figure, recorded in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 749.00 |
| Jun 30, 2019 | 749.00 |
| Jun 30, 2018 | 91.00 |
| Jun 30, 2018 | 91.00 |
| Sep 30, 2017 | -646.00 |
| Sep 30, 2017 | -646.00 |